Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5075196
Max Phase: Preclinical
Molecular Formula: C77H110N20O17S2
Molecular Weight: 1651.98
Molecule Type: Unknown
Associated Items:
ID: ALA5075196
Max Phase: Preclinical
Molecular Formula: C77H110N20O17S2
Molecular Weight: 1651.98
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCC[C@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]3CCCN3C(=O)[C@@H](CCCNC(=N)N)NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
Standard InChI: InChI=1S/C77H110N20O17S2/c1-5-7-27-49-65(104)87-50(29-18-33-83-77(80)81)74(113)96-34-20-31-58(96)71(110)94-61(43(3)6-2)72(111)93-55-41-115-116-42-56(69(108)95-62(44(4)98)73(112)90-52(37-46-23-13-9-14-24-46)67(106)88-51(66(105)86-49)36-45-21-11-8-12-22-45)92-64(103)48(28-17-32-82-76(78)79)85-59(99)40-84-63(102)53(39-60(100)101)89-70(109)57-30-19-35-97(57)75(114)54(91-68(55)107)38-47-25-15-10-16-26-47/h8-16,21-26,43-44,48-58,61-62,98H,5-7,17-20,27-42H2,1-4H3,(H,84,102)(H,85,99)(H,86,105)(H,87,104)(H,88,106)(H,89,109)(H,90,112)(H,91,107)(H,92,103)(H,93,111)(H,94,110)(H,95,108)(H,100,101)(H4,78,79,82)(H4,80,81,83)/t43-,44+,48-,49+,50+,51+,52+,53-,54-,55-,56-,57-,58-,61-,62-/m0/s1
Standard InChI Key: ROIBLPDAKVZLFD-NTOYLDHZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1651.98 | Molecular Weight (Monoisotopic): 1650.7799 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Muratspahić E, Tomašević N, Koehbach J, Duerrauer L, Hadžić S, Castro J, Schober G, Sideromenos S, Clark RJ, Brierley SM, Craik DJ, Gruber CW.. (2021) Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain., 64 (13.0): [PMID:34162205] [10.1021/acs.jmedchem.1c00158] |
Source(1):